235 related articles for article (PubMed ID: 35894117)
1. COVID-19 and diabetes: What do we know so far?
Gangadaran P; Padinjarathil H; Rajendran SHS; Jogalekar MP; Hong CM; Aruchamy B; Rajendran UM; Gurunagarajan S; Krishnan A; Ramani P; Subramanian K
Exp Biol Med (Maywood); 2022 Aug; 247(15):1330-1334. PubMed ID: 35894117
[TBL] [Abstract][Full Text] [Related]
2. Herbal-based therapeutics for diabetic patients with SARS-Cov-2 infection.
Rasmi Y; di Bari I; Faisal S; Haque M; Aramwit P; da Silva A; Roshani Asl E
Mol Biol Rep; 2024 Feb; 51(1):316. PubMed ID: 38376656
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 and diabetes: A bidirectional relationship.
Lima-Martínez MM; Carrera Boada C; Madera-Silva MD; Marín W; Contreras M
Clin Investig Arterioscler; 2021; 33(3):151-157. PubMed ID: 33303218
[TBL] [Abstract][Full Text] [Related]
4. Gene Networks of Hyperglycemia, Diabetic Complications, and Human Proteins Targeted by SARS-CoV-2: What Is the Molecular Basis for Comorbidity?
Saik OV; Klimontov VV
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806251
[TBL] [Abstract][Full Text] [Related]
5. Effect of Comorbid Diabetes on Clinical Characteristics of COVID-19 Patients Infected by the Wild-Type or Delta Variant of SARS-CoV-2.
Zhang J; Zhang J; Tao Z
Front Endocrinol (Lausanne); 2022; 13():861443. PubMed ID: 35600601
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 and diabetes-Two giants colliding: From pathophysiology to management.
Pelle MC; Zaffina I; Provenzano M; Moirano G; Arturi F
Front Endocrinol (Lausanne); 2022; 13():974540. PubMed ID: 36060943
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Deranged Glucose Metabolism and Diabetes in the Pathogenesis and Prognosis of the Novel SARS-CoV-2: A Systematic Review of Literature.
Ukwenya VO; Adelakun SA; Fuwape TA; Adeagbo AS
Curr Diabetes Rev; 2022; 18(3):e060821195355. PubMed ID: 34365925
[TBL] [Abstract][Full Text] [Related]
8. An overview of COVID-19 in people with diabetes: Pathophysiology and considerations in the inpatient setting.
Fleming N; Sacks LJ; Pham CT; Neoh SL; Ekinci EI
Diabet Med; 2021 Mar; 38(3):e14509. PubMed ID: 33377213
[TBL] [Abstract][Full Text] [Related]
9. Is diabetes mellitus a risk factor for COronaVIrus Disease 19 (COVID-19)?
Pugliese G; Vitale M; Resi V; Orsi E
Acta Diabetol; 2020 Nov; 57(11):1275-1285. PubMed ID: 32865671
[TBL] [Abstract][Full Text] [Related]
10. COVID-19, Hyperglycemia, and New-Onset Diabetes.
Khunti K; Del Prato S; Mathieu C; Kahn SE; Gabbay RA; Buse JB
Diabetes Care; 2021 Dec; 44(12):2645-2655. PubMed ID: 34625431
[TBL] [Abstract][Full Text] [Related]
11. Malnutrition management of hospitalized patients with diabetes/hyperglycemia and COVID-19 infection.
Burgos R; García-Almeida JM; Matía-Martín P; Palma S; Sanz-Paris A; Zugasti A; Alfaro JJ; Fullana AA; Continente AC; Chicetru MJ; Malpartida KG; Faes ÁG; Sánchez VG; López ML; Ortega AJM; Roldán JO; Moreno CS; Llanos PS
Rev Endocr Metab Disord; 2022 Apr; 23(2):205-213. PubMed ID: 35244834
[TBL] [Abstract][Full Text] [Related]
12. Role of secondary sepsis in COVID-19 mortality: Observations on patients with preexisting diabetes mellitus and newly diagnosed hyperglycemia.
Nair AM; Gopalan S; Rajendran V; Varadaraj P; Marappa L; Pandurangan V; Madhavan S; Mani R; Bhaskar E
Monaldi Arch Chest Dis; 2022 Apr; 92(4):. PubMed ID: 35416000
[TBL] [Abstract][Full Text] [Related]
13. Diabetes in the COVID-19 pandemic era.
Bonansea TCP; Santos LPD; Zintl K; Souza ACDS
Rev Assoc Med Bras (1992); 2021; 67Suppl 1(Suppl 1):157-162. PubMed ID: 34406303
[TBL] [Abstract][Full Text] [Related]
14. Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report.
Jornayvaz FR; Assouline B; Pugin J; Gariani K
BMC Endocr Disord; 2020 Oct; 20(1):155. PubMed ID: 33066762
[TBL] [Abstract][Full Text] [Related]
15. Diabetes and COVID-19; A Bidirectional Interplay.
Kazakou P; Lambadiari V; Ikonomidis I; Kountouri A; Panagopoulos G; Athanasopoulos S; Korompoki E; Kalomenidis I; Dimopoulos MA; Mitrakou A
Front Endocrinol (Lausanne); 2022; 13():780663. PubMed ID: 35250853
[TBL] [Abstract][Full Text] [Related]
16. Enhanced endocytosis elevated virulence and severity of SARS-CoV-2 due to hyperglycemia in type 2 diabetic patients.
Subbaram K; Ali PSS; Ali S
Gene Rep; 2022 Mar; 26():101495. PubMed ID: 35043090
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 and diabetes: Association intensify risk factors for morbidity and mortality.
Sharma P; Behl T; Sharma N; Singh S; Grewal AS; Albarrati A; Albratty M; Meraya AM; Bungau S
Biomed Pharmacother; 2022 Jul; 151():113089. PubMed ID: 35569351
[TBL] [Abstract][Full Text] [Related]
18. Glycemic Dysregulation, Inflammation and Disease Outcomes in Patients Hospitalized with COVID-19: Beyond Diabetes and Obesity.
Liontos A; Biros D; Kavakli A; Matzaras R; Tsiakas I; Athanasiou L; Samanidou V; Konstantopoulou R; Vagias I; Panteli A; Pappa C; Kolios NG; Nasiou M; Pargana E; Milionis H; Christaki E
Viruses; 2023 Jun; 15(7):. PubMed ID: 37515156
[TBL] [Abstract][Full Text] [Related]
19. New-Onset Diabetes After COVID-19.
Kim SH; Arora I; Hsia DS; Knowler WC; LeBlanc E; Mylonakis E; Pratley R; Pittas AG
J Clin Endocrinol Metab; 2023 Oct; 108(11):e1164-e1174. PubMed ID: 37207448
[TBL] [Abstract][Full Text] [Related]
20. Biologia Futura: is ADAM 17 the reason for COVID-19 susceptibility in hyperglycemic and diabetic patients?
Stepanova G
Biol Futur; 2021 Sep; 72(3):291-297. PubMed ID: 34554559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
